Quantum BioPharma Ltd. is trading 7.1% up at $4.17 as shares stage a relief bounce following a sharp selloff triggered by an FDA clinical hold on its lead drug candidate.
- The recent decline followed news that the FDA placed the company's multiple sclerosis candidate, Lucid-MS, on clinical hold.
- Today's upward move is characterized as dip-buying and a technical rebound rather than a reaction to fresh corporate news.
- Shares had fallen over several sessions as regulatory uncertainty weighed on investor sentiment.